Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Mantle-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 6Lymphoma, Follicular 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Burkitt Lymphoma 3Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Acute 1Composite Lymphoma 1Anemia 1

Interventions

ibrutinib 2fludarabine phosphate 1fludarabine 1acalabrutinib 1Whole-Body Irradiation 1Valganciclovir 1Therapeutics 1Tacrolimus 1Rituximab 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Mycophenolic Acid 1Mesna 1Melphalan 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Cyclophosphamide 1CT-P10 1Busulfan 1Antiviral Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Prolymphocytic × CT-P10 × Clear all
NCT02007044 2026-05-20

Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
66 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡